Published online 19 February 2009
Haematologica, Vol 94, Issue 4, 589-592 doi:10.3324/haematol.2008.000604
Copyright © 2009 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antón, A. I.
Right arrow Articles by Sánchez-Vega, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antón, A. I.
Right arrow Articles by Sánchez-Vega, B.

Thrombosis

Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels

Ana I. Antón, Raúl Teruel, Javier Corral, Antonia Miñano, Irene Martínez-Martínez, Adriana Ordóñez, Vicente Vicente, Beatriz Sánchez-Vega

Servicio de Hematología y Oncología Médica H.U. Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Spain

Correspondence: Javier Corral, Centro Regional de Hemodonación. C/ Ronda de Garay s/n. Murcia 30003. Spain. E-mail:javier.corral{at}carm.es

Genetic factors involved in the interindividual variability of antithrombin have not been identified. We studied two polymorphisms of the gene coding for antithrombin (SER-PINC1) in 298 Spanish Caucasian blood donors: rs3138521, a DNA length polymorphism located on the promoter region and rs2227589, a SNP located on intron 1 that has been described as a mild thrombotic risk factor. We detected a complete linkage disequilibrium between these polymorphisms (D’=0.999). The rs3138521 polymorphism has no functional consequences. However, the rs2227589 SNP significantly associated with plasma anti-FXa activity and antithrombin levels: carriers of the A allele had slightly but significantly lower anticoagulant activity and levels than GG subjects (97.0±7.3% vs. 94.6±8.4%; p=0.032; 99.5±5.8% vs. 94.8±5.6%; p=0.001; respectively). Our results identified a functional effect of the rs2227589 polymorphism not explained by its linkage with the promoter polymorphism that support the moderate thrombotic risk associated with the A allele.

Key words: antithrombin, polymorphism, thrombotic risk.